Navigating Global Compliance for Exosomes in Cosmetics: Insights into the US, Japan, South Korea, and China’s Taiwan

Exosomes have emerged as one of the most transformative ingredients in the global skincare industry, with the market projected to surge to USD 809.5 million by 2032. However, despite their immense potential, the regulatory landscape for these biological derivatives remains intricate and varies across jurisdictions.

While some regions strictly prohibit human-derived ingredients, others, like China's Taiwan, have recently opened pathways through case-by-case reviews. In the US, the focus lies on MoCRA compliance and INCI/DMF filings, while Japan and South Korea impose rigorous safety standards for these ingredients.

To help industry players navigate these complexities, ChemLinked has invited Cinny Hu, a Senior Regulatory Specialist from REACH24H, to decode the compliance requirements for exosomes. This session will provide a deep dive into the regulatory frameworks of the US, Japan, South Korea, and China's Taiwan, offering actionable strategies for global market entry.

Notes:
1. The webinar livestreaming is freely available to all users. You are welcome to register for and participate in the webinar.
2. Kindly be aware that the access to the slides and recording is limited to ChemLinked premium members only [Upgrade now].

1. Market Trends & Background

2. Compliance Pathways for Exosomes in the Cosmetics Field

• The US

• Japan

• South Korea

• China's Taiwan

3. Compliance Advice

4. Q&A

*The final outline may be subjected to subtle revision

If you have any questions about this webinar, please contact us at:

EMAIL: [email protected]

TEL: +86 (0) 571 8609 4444